Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Litvinenko Assassinated by "Nuclear Hit Men": The Tenth Anniversary
  • USA - English


News provided by

Nov 04, 2016, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Alexander Litvinenko, after being poisoned with polonium-210
Alexander Litvinenko, after being poisoned with polonium-210

Atlanta, GA (PRWEB) November 04, 2016 -- November 23rd is the tenth anniversary of Alexander Litvinenko’s death. Litvinenko is the Russian ex-secret service operative who, according to United Kingdom authorities, was assassinated with a unique poison, which most experts agree could only be manufactured by a clandestine state-sponsored activity. The poison is the radioactive isotope, polonium-210. Ingesting an amount the equivalent to the size of the period at the end of this sentence is fatal.

Polonium poisoning is only one of several additional ways extremists could engage in nuclear terrorism today.

Post this

Litvinenko had been granted asylum in the U.K. where he reportedly investigated undercover Russian individuals and companies. In Russia, he was an officer in the KGB and later the Federal Security Service, a position he’d been dismissed from after he publicly announced illegal activity within the organization.

On Nov. 1, 2006, Litvinenko met over tea in the bar of the Millennium Hotel in London with two men, reportedly a former KGB bodyguard and a Red Army deserter. That evening, Litvinenko arrived at a local hospital with acute abdominal pain where he died 22 days later, all of his primary organs having failed. It was discovered only hours before his death, that he had been poisoned with the radioactive polonium-210, which had been placed into his tea. An investigative report commissioned in the U.K. and released earlier this year (http://www.litvinenkoinquiry.org) concluded that there is a “strong circumstantial case that the Russian State was responsible for Mr. Litvinenko’s death.”

We are all aware of the ultimate terrorist threat of a nuclear weapon or an improvised nuclear device. (The latter is often referred to as the "Hiroshima in a suitcase.”) Polonium poisoning is only one of several additional ways extremists could engage in nuclear terrorism today. For example, there’s the “silent source” scenario, where a covert source of radiation is employed to expose people. Then there is the feared “dirty bomb” plot: lacing a conventional bomb with a radioactive isotope like cobalt 60 that emits highly penetrating gamma rays. These possibilities emphasize and reaffirm the importance of radioactive source security in nuclear power plants, universities where radioactive isotopes are widespread for research purposes, hospitals with nuclear medicine departments, and cancer clinics that provide radiation therapy. And that's only a short list.

The opportunity for smuggling nuclear material and using it as a weapon of terrorism today is greater than ever. According to the International Atomic Energy Agency (IAEA) in Vienna, over a recent ten-year period there have been more than fifteen hundred confirmed incidents of illicit trafficking of nuclear and radiological materials worldwide. Tens of thousands of these potent radioactive sources are in private hands. Experts tell us that much of the world's smuggled nuclear material is traceable to stockpiles in Russia and other former Soviet nations, where many research facilities remain poorly protected by underpaid guards, maintenance staff, and unreliable security systems. Today, internationally organized crime and criminal gangs could make sizeable profits from the sale of radioactive sources to extremist groups.

Bottom line: First, awareness by everyone about possibilities far beyond “typical” terrorist scenarios. Beyond that, vigilance and security are required with all things nuclear.

         * * *

James Marshall Smith, Ph.D. was chief of radiation studies for the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta from 1991-2003, a consultant on nuclear-threat countermeasures for the International Atomic Energy Agency (IAEA) in Vienna, and an advisor to the White House Office of Science and Technology Policy in the wake of 9/11. Part of this report was taken from the account in his medical thriller, "Silent Source" (Stealth Books, Oct. 2016), inspired by one of the U.S. Department of Homeland Security’s top scenarios for terrorist attacks on the U.S. For more information on Smith, visit http://www.JamesMarshallSmith.com.

James Marshall Smith, Ph.D., http://www.jamesmarshallsmith.com, +1 678-200-9041, [email protected]

Modal title

James Marshall Smith, Ph.D., is former Chief of Radiation Studies, Centers for Disease Control and Prevention. His debut novel, "Silent Source," is an award-winning thriller released last month.
James Marshall Smith, Ph.D., is former Chief of Radiation Studies, Centers for Disease Control and Prevention. His debut novel, "Silent Source," is an award-winning thriller released last month.
James Marshall Smith, Ph.D., is former Chief of Radiation Studies, Centers for Disease Control and Prevention. His debut novel, "Silent Source," is an award-winning thriller released last month.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.